BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33851708)

  • 1. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
    Zhu YZ; Liu Y; Liao XW; Luo SS
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.
    Xie Y; Gou Q; Xie K; Wang Z; Wang Y; Zheng H
    Oncotarget; 2016 Sep; 7(38):61273-61283. PubMed ID: 27542224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
    Zhu C; Xiao D
    Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis.
    Yin Z; Wu D; Shi J; Wei X; Jin N; Lu X; Ren X
    BMC Cancer; 2020 Nov; 20(1):1062. PubMed ID: 33148208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS19 Suppresses Cell Migration and Invasion by Targeting S100A16 via the NF-κB Pathway in Human Gastric Cancer.
    Jiang Y; Yu X; Zhao Y; Huang J; Li T; Chen H; Zhou J; Huang Z; Yang Z
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
    Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer.
    Luo S; Lin R; Liao X; Li D; Qin Y
    Sci Rep; 2021 Dec; 11(1):23674. PubMed ID: 34880371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Values for the mRNA Expression of the ADAMTS Family of Genes in Gastric Cancer.
    Liang L; Zhu JH; Chen G; Qin XG; Chen JQ
    J Oncol; 2020; 2020():9431560. PubMed ID: 32884571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
    Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
    DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 11. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities.
    Chen Y; Xiao C; Fan Q; Zhang Y; Huang Q; Ou Y
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):151. PubMed ID: 38682182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
    Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
    Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trim47 overexpression correlates with poor prognosis in gastric cancer.
    Xia Y; Wei Z; Huang W; Wei X; He Y
    Neoplasma; 2021 Mar; 68(2):307-316. PubMed ID: 33350849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
    Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y
    Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
    Lv X; Zhao Y; Zhang L; Zhou S; Zhang B; Zhang Q; Jiang L; Li X; Wu H; Zhao L; Wei M; He M
    J Cell Biochem; 2020 Feb; 121(2):1842-1854. PubMed ID: 31633246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
    Tan Y; Chen Q; Xing Y; Zhang C; Pan S; An W; Xu H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
    He XY; Zhao J; Chen ZQ; Jin R; Liu CY
    Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.
    Wu Y; Grabsch H; Ivanova T; Tan IB; Murray J; Ooi CH; Wright AI; West NP; Hutchins GG; Wu J; Lee M; Lee J; Koo JH; Yeoh KG; van Grieken N; Ylstra B; Rha SY; Ajani JA; Cheong JH; Noh SH; Lim KH; Boussioutas A; Lee JS; Tan P
    Gut; 2013 Aug; 62(8):1100-11. PubMed ID: 22735568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.